370 related articles for article (PubMed ID: 7514493)
1. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.
Fontenot JD; Tjandra N; Bu D; Ho C; Montelaro RC; Finn OJ
Cancer Res; 1993 Nov; 53(22):5386-94. PubMed ID: 8221676
[TBL] [Abstract][Full Text] [Related]
3. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ
Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586
[TBL] [Abstract][Full Text] [Related]
5. Human B-cell immune response to the polymorphic epithelial mucin.
Rughetti A; Turchi V; Ghetti CA; Scambia G; Panici PB; Roncucci G; Mancuso S; Frati L; Nuti M
Cancer Res; 1993 Jun; 53(11):2457-9. PubMed ID: 8495404
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
7. A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.
Goydos JS; Elder E; Whiteside TL; Finn OJ; Lotze MT
J Surg Res; 1996 Jun; 63(1):298-304. PubMed ID: 8667619
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biological analyses of mucin core proteins and their clinical application].
Hinoda Y; Imai K
Gan To Kagaku Ryoho; 1994 Feb; 21(2):150-6. PubMed ID: 8311484
[TBL] [Abstract][Full Text] [Related]
9. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin.
Doménech N; Henderson RA; Finn OJ
J Immunol; 1995 Nov; 155(10):4766-74. PubMed ID: 7594478
[TBL] [Abstract][Full Text] [Related]
10. [New mucin core protein genes and their clinical application].
Imai K
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):139-43. PubMed ID: 8641670
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of anti-human milk fat globule antibodies with synthetic peptides.
Xing PX; Tjandra JJ; Reynolds K; McLaughlin PJ; Purcell DF; McKenzie IF
J Immunol; 1989 May; 142(10):3503-9. PubMed ID: 2715633
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
13. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
Burchell J; Taylor-Papadimitriou J
Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
[TBL] [Abstract][Full Text] [Related]
14. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.
Ioannides CG; Fisk B; Jerome KR; Irimura T; Wharton JT; Finn OJ
J Immunol; 1993 Oct; 151(7):3693-703. PubMed ID: 7690810
[TBL] [Abstract][Full Text] [Related]
16. Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.
Denton G; Sekowski M; Price MR
Cancer Lett; 1993 Jul; 70(3):143-50. PubMed ID: 7689035
[TBL] [Abstract][Full Text] [Related]
17. Does pregnancy immunize against breast cancer?
Agrawal B; Reddish MA; Krantz MJ; Longenecker BM
Cancer Res; 1995 Jun; 55(11):2257-61. PubMed ID: 7538899
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
Jerome KR; Domenech N; Finn OJ
J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
[TBL] [Abstract][Full Text] [Related]
19. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins.
Byrd JC; Ho JJ; Lamport DT; Ho SB; Siddiki B; Huang J; Yan PS; Kim YS
Cancer Res; 1991 Feb; 51(3):1026-33. PubMed ID: 1988113
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
